The Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a collaborative study by scientists from the Perelman School of Medicine at the University of Pennsylvania; Inovio Biosciences, Inc; and MedImmune Inc., the global biologics research and development arm of AstraZeneca, Inc.![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
↧